Check the mail online click here
|
|
|
Newsletter #56
|
|
Welcome to the 56th edition of our newsletter.
This issue features an interview with Fabien Le Grand, a researcher at the Myology Centre for Research who has recently published an article about the role of the Wnt/b-catenin signalling pathway in muscle stem cells and its impact on their regenerative potential. The findings of this exciting study represent a significant advance in muscle stem cell biology and muscle regeneration.
Our newsletter also highlights select publications from international research teams and teams at the Institute and brings you information on upcoming events and recent calls for proposal.
|
At the Institute |
Fabien Le Grand : Wnt/b-catenin pathway and muscle regeneration
Fabien Le Grand (team 3 at the Myology Centre for Research) have published an article in Cell Reports concerning Wnt/b-catenin activation in adult muscle progenitor cells.
Read more
|
Next seminars at the Institute
Next seminars will be given by Dr Patrice Petit (Université Paris Descartes France) on Barth Syndrome, and by Franceso Saverio Tedesco (University College London, UK) on Human Artificial Chromosomes and iPS cells.
Read more
|
Our latest news |
AIRE, key factor in the gender inequality for autoimmune diseases
To prove this inequality, the researchers from the Institute of Myology looked into the mechanisms of thymic tolerance, meaning a state of immune non-response while facing an antigen.
Read more
|
Cancer screening in necrotizing autoimmune myopathies
Anti-signal recognition particle or anti-HMGCR antibodies have been specifically associated with necrotizing autoimmune myopathies.
Read more
|
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
Cardiac alterations, characterised by conduction delays and arrhythmia, are the second most common cause of death in Myotonic dystrophy.
Read more
|
Defining the natural history of LGMD2A
This observational study is investigating the clinical manifestations and disease progression in genetically confirmed LGMD2A.
Read more
|
High respiratory morbidity in severely respiratory impaired LGMD type 2C and 2D patients
This study aimed to describe the long-term cardiac and respiratory follow-up of LGMD patients (from 2005 to 2015).
Read more
|
Use of advanced MRI methods to quantify spinal cord atrophy in SMN1-linked SMA
The mechanisms underlying the topography of motor deficits in spinal muscular atrophy remain unknown.
Read more
|
International breaking news |
Phase I study of SMT C1100 in paediatric DMD patients
SMT C1100 is a utrophin modulator being evaluated as a treatment for Duchenne muscular dystrophy.
Read more
|
Identification of novel SMCHD1 mutations in Japanese FSHD2 patients
FSHD2 has not been studied in Asian populations. Therefore, it is not known whether this disease mechanism is widely seen.
Read more
|
Spinal muscular atrophy
|
Duchenne muscular dystrophy
|
Myasthenia gravis
|
Other neuromuscular diseases and basic research
|
In brief |
AFM-Téléthon: International Call for Translational Research Projects on RNA
The AFM-Téléthon has announced the launch of its first international call for proposals for Translational Research Projects on RNA as a therapeutic target or therapeutic product. It is opened from 17 May to 28 June 2016.
Read more
|
Italian Telethon Undiagnosed Diseases Program
The Telethon Undiagnosed Diseases Program (UDP) pursues the goal of providing a diagnosis to paediatric patients with a genetic disease without a name.
Read more
|
Science Award for Rare Diseases 2016
This award honours outstanding research projects in the area of rare diseases affecting children. Applications must be submitted electronically by June 30, 2016.
Read more
|
Job opportunities
Post-doctoral positions are available at University of Oxford (UK) and at Mondor Institute of Biomedical Research (France).
Read more
|
Latest Publications from the Institute |
Weiss, J. M.,Robinet, M.,Aricha, R.,Cufi, P.,Villeret, B.,Lantner, F.,Shachar, I.,Fuchs, S.,Souroujon, M. C.,Berrih-Aknin, S.,Le Panse, R.
Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis
Oncotarget, 2016 ; 7 (7) : 7550-62
Maggio, I.,Stefanucci, L.,Janssen, J. M.,Liu, J.,Chen, X.,Mouly, V.,Goncalves, M. A.
Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations
Nucleic Acids Res, 2016 ; 44 (3) : 1449-70
Marsollier, A. C.,Ciszewski, L.,Mariot, V.,Popplewell, L.,Voit, T.,Dickson, G.,Dumonceaux, J.
Antisense targeting of 3'end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for Facioscapulohumeral Dystrophy: a new gene silencing approach
Hum Mol Genet, 2016 ; 25 (8) : 1468-78
Possidonio, A. C.,Soares, C. P.,Fontenelle, M.,Morris, E. R.,Mouly, V.,Costa, M. L.,Mermelstein, C.
Knockdown of Lmo7 inhibits chick myogenesis
FEBS Lett, 2016 ; 590 (3) : 317-29
Marty, B.,Baudin, P. Y.,Reyngoudt, H.,Azzabou, N.,Araujo, E. C.,Carlier, P. G.,de Sousa, P. L.
Simultaneous muscle water T and fat fraction mapping using transverse relaxometry with stimulated echo compensation
NMR Biomed, 2016 ; 29 (4) : 431-43
Allenbach, Y.,Leroux, G.,Suarez-Calvet, X.,Preusse, C.,Gallardo, E.,Hervier, B.,Rigolet, A.,Hie, M.,Pehl, D.,Limal, N.,Hufnagl, P.,Zerbe, N.,Meyer, A.,Aouizerate, J.,Uzunhan, Y.,Maisonobe, T.,Goebel, H. H.,Benveniste, O.,Stenzel, W.,French Myositis, Network
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression
Am J Pathol, 2016 ; 186 (3) : 691-700
Hogrel, J. Y.,Wary, C.,Moraux, A.,Azzabou, N.,Decostre, V.,Ollivier, G.,Canal, A.,Lilien, C.,Ledoux, I.,Annoussamy, M.,Reguiba, N.,Gidaro, T.,Le Moing, A. G.,Cardas, R.,Voit, T.,Carlier, P. G.,Servais, L.
Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy
Neurology, 2016 ; 86 (11) : 1022-30
Willkomm, L.,Heredia, R.,Hoffmann, K.,Wang, H.,Voit, T.,Hoffman, E. P.,Cirak, S.
Homozygous mutation in Atlastin GTPase 1 causes recessive hereditary spastic paraplegia
J Hum Genet, 2016 ; :
Stergiou, C.,Lazaridis, K.,Zouvelou, V.,Tzartos, J.,Mantegazza, R.,Antozzi, C.,Andreetta, F.,Evoli, A.,Deymeer, F.,Saruhan-Direskeneli, G.,Durmus, H.,Brenner, T.,Vaknin, A.,Berrih-Aknin, S.,Behin, A.,Sharshar, T.,De Baets, M.,Losen, M.,Martinez-Martinez, P.,Kleopa, K. A.,Zamba-Papanicolaou, E.,Kyriakides, T.,Kostera-Pruszczyk, A.,Szczudlik, P.,Szyluk, B.,Lavrnic, D.,Basta, I.,Peric, S.,Tallaksen, C.,Maniaol, A.,Gilhus, N. E.,Casasnovas Pons, C.,Pitha, J.,Jakubikova, M.,Hanisch, F.,Bogomolovas, J.,Labeit, D.,Labeit, S.,Tzartos, S. J.
Titin antibodies in "seronegative" myasthenia gravis - A new role for an old antigen
J Neuroimmunol, 2016 ; 292 : 108-15
Bouchereau, J.,Barrot, S. V.,Dupre, T.,Moore, S. E.,Cardas, R.,Capri, Y.,Gaignard, P.,Slama, A.,Delanoe, C.,de Baulny, H. O.,Seta, N.,Schiff, M.,Servais, L.
Abnormal Glycosylation Profile and High Alpha-Fetoprotein in a Patient with Twinkle Variants
JIMD Rep, 2016 ; :
Wahbi, K.,Sebag, F. A.,Lellouche, N.,Lazarus, A.,Becane, H. M.,Bassez, G.,Stojkovic, T.,Fayssoil, A.,Laforet, P.,Behin, A.,Meune, C.,Eymard, B.,Duboc, D.
Atrial flutter in myotonic dystrophy type 1: Patient characteristics and clinical outcome
Neuromuscul Disord, 2016 ; 26 (3) : 227-33
Davignon, L.,Chauveau, C.,Julien, C.,Dill, C.,Duband-Goulet, I.,Cabet, E.,Buendia, B.,Lilienbaum, A.,Rendu, J.,Minot, M. C.,Guichet, A.,Allamand, V.,Vadrot, N.,Faure, J.,Odent, S.,Lazaro, L.,Leroy, J. P.,Marcorelles, P.,Dubourg, O.,Ferreiro, A.
The transcription coactivator ASC-1 is a regulator of skeletal myogenesis, and its deficiency causes a novel form of congenital muscle disease
Hum Mol Genet, 2016 ; 25 (8) : 1559-73
Dragin, N.,Bismuth, J.,Cizeron-Clairac, G.,Biferi, M. G.,Berthault, C.,Serraf, A.,Nottin, R.,Klatzmann, D.,Cumano, A.,Barkats, M.,Le Panse, R.,Berrih-Aknin, S.
Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases
J Clin Invest, 2016 ; 126 (4) : 1525-37
Behin, A.,Acquaviva-Bourdain, C.,Souvannanorath, S.,Streichenberger, N.,Attarian, S.,Bassez, G.,Brivet, M.,Fouilhoux, A.,Labarre-Villa, A.,Laquerriere, A.,Perard, L.,Kaminsky, P.,Pouget, J.,Rigal, O.,Vanhulle, C.,Eymard, B.,Vianey-Saban, C.,Laforet, P.
Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease
Rev Neurol (Paris), 2016 ; :
|
|
Newsletter subscription
Find out every two months the news from myology Every two months, the newsletter from the Institute of Myology informed you on developments in myology research, with a summary of the latest scientifics news, medical, political and community about neuromuscular diseases. You can read our newsletter by subscribing. You can unsubscribe here. |
|
Also follow our news on social networks
|
|
Legal
This is the newsletter of current medical science from the Institute of Myology. It is published every two months. Chief Editor: Gaëlle Barrier Editorial Board: Marianne Perreau-Saussine; J. Andoni Urtizberea. Redaction: Racquel N. Cooper; Anne Berthomier. Also participate: Nathalie Haslin. Do you have any questions? Would you like to share some news? Please contact us. © 2015 - AFM - Institut de Myologie. ISSN 1772-9866 |
|
|